1.
Rationale, design, and baseline characteristics of the Canagliflozin Cardiovascular Assessment Study (CANVAS)—A randomized placebo-controlled trial
by Neal, Bruce, PhD
The American heart journal, 2013, Vol.166 (2), p.217-223.e11
